Viatris has revealed that the FDA has restricted imports of 11 products made at its Indian facility after an inspection found violations of federal requirements. The affected products will not be accepted in the U.S. until the issue is resolved. The site makes oral finished doses like tablets and capsules. Viatris is working on corrective actions.
